US Bancorp’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $801K | Buy |
7,517
+140
| +2% | +$17K | ﹤0.01% | 1317 |
|
|
2026
Q1 | $1.21M | Sell |
7,377
-371
| -5% | -$57K | ﹤0.01% | 1064 |
|
|
2025
Q4 | $1.35M | Sell |
7,748
-903
| -10% | -$165K | ﹤0.01% | 1033 |
|
|
2025
Q3 | $1.25M | Sell |
8,651
-1,101
| -11% | -$135K | ﹤0.01% | 1056 |
|
|
2025
Q2 | $981K | Sell |
9,752
-1,571
| -14% | -$120K | ﹤0.01% | 1117 |
|
|
2025
Q1 | $864K | Buy |
11,323
+1,790
| +19% | +$137K | ﹤0.01% | 1153 |
|
|
2024
Q4 | $658K | Buy |
9,533
+1,601
| +20% | +$115K | ﹤0.01% | 1340 |
|
|
2024
Q3 | $579K | Buy |
7,932
+2,824
| +55% | +$208K | ﹤0.01% | 1430 |
|
|
2024
Q2 | $342K | Buy |
5,108
+461
| +10% | +$17.9K | ﹤0.01% | 1716 |
|
|
2024
Q1 | $126K | Buy |
4,647
+231
| +5% | +$6.46K | ﹤0.01% | 2241 |
|
|
2023
Q4 | $137K | Buy |
4,416
+4,222
| +2,176% | +$109K | ﹤0.01% | 2198 |
|
|
2023
Q3 | $4.9K | Sell |
194
-332
| -63% | -$7.59K | ﹤0.01% | 3437 |
|
|
2023
Q2 | $11.1K | Buy |
526
+307
| +140% | +$5.83K | ﹤0.01% | 3219 |
|
|
2023
Q1 | $3.73K | Buy |
+219
| New | +$4.25K | ﹤0.01% | 3617 |
|
|
2022
Q4 | – | Sell |
-16
| Closed | – | – | 4210 |
|
|
2022
Q3 | $0 | Buy |
+16
| New | +$384 | ﹤0.01% | 4137 |
|
|
2022
Q2 | – | Sell |
-646
| Closed | -$15K | – | 4139 |
|
|
2022
Q1 | $15K | Sell |
646
-1,103
| -63% | -$25.6K | ﹤0.01% | 3222 |
|
|
2021
Q4 | $47K | Sell |
1,749
-820
| -32% | -$23.4K | ﹤0.01% | 2691 |
|
|
2021
Q3 | $70K | Buy |
2,569
+2,020
| +368% | +$53K | ﹤0.01% | 2477 |
|
|
2021
Q2 | $15K | Buy |
549
+21
| +4% | +$623 | ﹤0.01% | 3262 |
|
|
2021
Q1 | $18K | Buy |
528
+67
| +15% | +$2.56K | ﹤0.01% | 3074 |
|
|
2020
Q4 | $15K | Hold |
461
| – | – | ﹤0.01% | 3022 |
|
|
2020
Q3 | $15K | Buy |
461
+55
| +14% | +$1.58K | ﹤0.01% | 2932 |
|
|
2020
Q2 | $11K | Buy |
+406
| New | +$9.63K | ﹤0.01% | 3070 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | -$6K | – | 3636 |
|
|
2019
Q1 | $6K | Sell |
200
-282
| -59% | -$7.31K | ﹤0.01% | 3192 |
|
|
2018
Q4 | $6K | Hold |
482
| – | – | ﹤0.01% | 3164 |
|
|
2018
Q3 | $10K | Sell |
482
-144
| -23% | -$3.25K | ﹤0.01% | 3117 |
|
|
2018
Q2 | $15K | Sell |
626
-55
| -8% | -$1.42K | ﹤0.01% | 3022 |
|
|
2018
Q1 | $15K | Sell |
681
-732
| -52% | -$19.3K | ﹤0.01% | 3027 |
|
|
2017
Q4 | $44K | Buy |
1,413
+724
| +105% | +$21.4K | ﹤0.01% | 2661 |
|
|
2017
Q3 | $22K | Buy |
689
+481
| +231% | +$9.16K | ﹤0.01% | 2861 |
|
|
2017
Q2 | $3K | Buy |
208
+97
| +87% | +$1.66K | ﹤0.01% | 3324 |
|
|
2017
Q1 | $2K | Buy |
111
+44
| +66% | +$679 | ﹤0.01% | 3396 |
|
|
2016
Q4 | $1K | Buy |
+67
| New | +$914 | ﹤0.01% | 3451 |
|
|
2016
Q3 | – | Sell |
-2,003
| Closed | -$20K | – | 3570 |
|
|
2016
Q2 | $20K | Buy |
2,003
+528
| +36% | +$6.16K | ﹤0.01% | 2796 |
|
|
2016
Q1 | $19K | Sell |
1,475
-1,688
| -53% | -$22.2K | ﹤0.01% | 2776 |
|
|
2015
Q4 | $57K | Buy |
3,163
+807
| +34% | +$14.2K | ﹤0.01% | 2378 |
|
|
2015
Q3 | $44K | Buy |
+2,356
| New | +$58.8K | ﹤0.01% | 2521 |
|
Other funds holding INSM
BBA
DGM
OAG
US Bancorp's INSM Position: Q2 2026 in Review
US Bancorp increased its Insmed (INSM) stake by 1.9% in Q2 2026, buying an estimated $17K and bringing the position to 7,517 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.
US Bancorp first reported a position in INSM in Q3 2015 and has held it in 37 quarters since. The position peaked at $1.35M in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- US Bancorp held 7,517 shares of Insmed worth $801K as of Q2 2026.
- US Bancorp bought 140 Insmed shares in Q2 2026, an estimated $17K.
- Insmed made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1317 holding.
- US Bancorp first reported a position in Insmed in Q3 2015 and has held it in 37 quarters since.
- US Bancorp's Insmed position peaked at $1.35M in Q4 2025.
- 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.